//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Investigative reporter @sciencemagazine. Before: investigations for @statnews @sacbee_news @latimes. [email protected] - Signal: cpiller.01 - Author of the book "Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's"
Charles Piller









Loading...
Glad to see that the litany of defects in the $13B SF-Oakland Bay Bridge have not been totally forgotten. Decent intro via MegaBuilds: www.youtube.com/watch?v=NAr9... I spent years investigating those. They were ignored or never adequately fixed. Among many articles: www.sacbee.com/news/investi...
11d
Thanks to Stephen J. Dubner, Dalvin Aboagye, and colleagues for having me on a great Freakonomics episode about Alzheimer's and my book Doctored. freakonomics.com/podcast/why-...
For readers in the UK and Commonwealth nations - Doctored is now out in paperback bit.ly/4clbKIL
1mo
The Fight Over Antisemitism Studies - thoughtful, nuanced reporting by @stephaniemlee.bsky.social www.chronicle.com/article/the-...
A conference taught me that scientists and journalists must work together to protect research - great insights from @lonnibesancon.bsky.social www.nature.com/articles/d41...
U.S. researchers face new restrictions on publishing with foreign collaborators - sobering report by @jeffreybrainard.bsky.social | Science | AAAS www.science.org/content/arti...
Medicare is spending far less than expected on new Alzheimer’s drugs www.statnews.com/2026/05/11/m... via @statnews.com @bobjherman.bsky.social
A monumental head-scratcher: Why won't the journal just retract the study? Judge tosses lawsuit over controversial Paxil ‘Study 329’ retractionwatch.com/2026/04/02/j...
“Game-changer” breast cancer study retracted as Indiana researcher out of his post - findings by @thatsregrettab1.bsky.social retractionwatch.com/2026/04/15/g...
2mo
If you’re in the Boston area, please join me on April 16 for my talk about the tragedy of fraudulent or false Alzheimer’s research – and the response to my book “Doctored.” Talk and reception sponsored by MIT Knight Science Journalism. ksj.mit.edu/event/lectur...
27d
21d
15d
28d
Charles Piller
2mo
1mo
2mo
Charles Piller
Science sleuth Lonni Besançon realizes that he has sometimes misunderstood what the media want from him and his researcher colleagues.
www.nature.com
A conference taught me that scientists and journalists must work together to protect research
Charles Piller
Charles Piller
Charles Piller
Charles Piller
Charles Piller
Charles Piller
Charles Piller
Charles Piller
freakonomics.com
YouTube video by MegaBuilds
www.youtube.com
The Most Expensive Bridge in US History Is Quietly Falling Apart
The Fight Over Antisemitism Studies
How money, fear, and October 7th forged a contentious new area of study.
www.chronicle.com
NIH, NASA grantees are confused and concerned amid agencies’ piecemeal communication
www.science.org
U.S. researchers face new restrictions on publishing with foreign collaborators
Join Charles Piller, a correspondent for Science and investigative reporter, as he discusses his book “Doctored,” an examination into how unscrupulous researchers, government enablers, and Pharma exec...
ksj.mit.edu
Lecture: Investigating Fraud, Arrogance, and Tragedy in Alzheimer's Research A Talk and Discussion With Investigative Reporter Charles Piller - Knight Science Journalism @MIT
Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are uncertain.
www.statnews.com
Medicare is spending far less than expected on new Alzheimer’s drugs
A group of cancer researchers whose work has been questioned by sleuths has been hit with their third retraction in less than a year.   Today, Science Translational Medicine (STM) withdre…
retractionwatch.com
A judge has dismissed a legal challenge aimed at forcing Elsevier to retract a long-criticized study that concluded the antidepressant Paxil was safe and effective for teens. The 2001 paper, publis…
retractionwatch.com
“Game-changer” breast cancer study retracted as Indiana researcher out of his post
Judge tosses lawsuit over controversial Paxil ‘Study 329’